PCVX
$35.93
Revenue | $0Mn |
Net Profits | $-140.72Mn |
Net Profit Margins | -Inf% |
Vaxcyte Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q1 2025. On a quarterly growth basis, Vaxcyte Inc has generated NaN% jump in its revenue since last 3-months.
Vaxcyte Inc’s net profit fell -48.09% since last year same period to $-140.72Mn in the Q1 2025. On a quarterly growth basis, Vaxcyte Inc has generated -2.65% fall in its net profits since last 3-months.
Vaxcyte Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q1 2025. On a quarterly growth basis, Vaxcyte Inc has generated NaN% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -1.23 |
EPS Estimate Current Year | -1.23 |
Vaxcyte Inc’s earning per share (EPS) estimates for the current quarter stand at -1.23 - a -5.13% fall from last quarter’s estimates.
Vaxcyte Inc’s earning per share (EPS) estimates for the current year stand at -1.23.
Earning Per Share (EPS) | 0 |
Vaxcyte Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Vaxcyte Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-11-10 | -1.23 | 0 | 100% |
2025-05-07 | -0.98 | -1.04 | -6.67% |
2025-08-12 | -1.17 | 0 | 100% |